The following projects were either funded, given the go ahead or started in the last two months:
Systematic review and cost-effectiveness of eculizumab for paroxysmal nocturnal hemoglobinuria. Contact Eva Kaltenthaler for further details.
Cost-effectiveness of screening for Type 2 diabetes. Contact Mike Gillett for further details.
Systematic review of the epidemiology of advanced melanoma in the UK. Contact Roberta Ara for further details.
